Tissue Engineering and Regenerative Medicine represent groundbreaking fields at the intersection of biology, engineering, and medicine, aimed at restoring, maintaining, or enhancing tissue and organ function. Tissue engineering involves the manipulation of cells, biomaterials, and biochemical factors to create functional tissue substitutes that can regenerate, repair, or replace damaged or diseased tissues. Regenerative medicine, on the other hand, focuses on stimulating the body's own repair mechanisms to heal tissues or organs that have been damaged by injury, disease, or aging. These fields offer promising solutions to a wide range of medical challenges, including organ failure, tissue loss, and degenerative diseases. By harnessing the body's natural regenerative processes and combining them with advances in materials science, biotechnology, and bioengineering, researchers can develop innovative therapies and treatments. From engineering tissues for transplantation to designing biomaterial scaffolds that promote tissue regeneration, the possibilities are vast. One key aspect of tissue engineering and regenerative medicine is the use of stem cells, which have the remarkable ability to differentiate into various cell types. Stem cell-based therapies hold great potential for repairing and regenerating damaged tissues and organs. Additionally, advances in gene editing technologies, such as CRISPR-Cas9, are enabling researchers to precisely modify the genetic makeup of cells, further enhancing their therapeutic potential. Furthermore, the development of biocompatible materials, such as hydrogels, scaffolds, and bioinks, is crucial for creating three-dimensional structures that mimic the complex architecture of native tissues. These materials provide mechanical support and biochemical cues to guide cell growth and tissue formation.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt